Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

captopril

A sulfhydryl-containing analog of proline with antihypertensive activity and potential antineoplastic activity. Captopril competitively inhibits angiotensin converting enzyme (ACE), thereby decreasing levels of angiotensin II, increasing plasma renin activity, and decreasing aldosterone secretion. This agent may also inhibit tumor angiogenesis by inhibiting endothelial cell matrix metalloproteinases (MMPs) and endothelial cell migration. Captopril may also exhibit antineoplastic activity independent of effects on tumor angiogenesis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Capoten
Abbreviation:CPT
Chemical structure:(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search